Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
Titel:
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
Auteur:
Dodel, Richard Rominger, Axel Bartenstein, Peter Barkhof, Frederik Blennow, Kaj Förster, Stefan Winter, Yaroslav Bach, Jan-Philipp Popp, Julius Alferink, Judith Wiltfang, Jens Buerger, Katharina Otto, Markus Antuono, Piero Jacoby, Michael Richter, Ralph Stevens, James Melamed, Isaac Goldstein, Jerome Haag, Stefan Wietek, Stefan Farlow, Martin Jessen, Frank